Table 1.
Demographic, clinical, and endocrine characteristics.
| ACM (n = 108) | Control (n = 108) | p value | |
|---|---|---|---|
| Male, n (%) | 44 (41) | 44 (41) | >0.99 |
| Age, years | 41.2 ± 12.7 | 41.2 ± 13.5 | 0.79 |
| BMI, kg/m2 | 27.4 ± 5.7 | 26.2 ± 4.0 | 0.11 |
| Smoking, n (%) | 46 (43) | 53 (49) | 0.34 |
| HT, n (%) | 30 (28) | 41 (38) | 0.11 |
| DM, n (%) | 59 (55) | 25 (23) | <0.001 |
| Dyslipidemia, n (%) | 15 (14) | 17 (16) | 0.70 |
| Nadir GH, ng/mL | 21.4 ± 39.3 | — | — |
| Fasting GH, ng/mL | 27.4 ± 44.6 | — | — |
| IGF-1, ng/mL | 802.7 ± 337.5 | — | — |
| DD, month | 77.8 ± 63.0 | — | — |
The data are presented as mean ± SD. ACM = acromegaly; BMI = body mass index; HT = hypertension; DM = diabetes mellitus; IGF-1 = insulin-like growth factor 1; and DD = disease duration.